Sept 29 (Reuters) – Metsera Inc: * METSERA REPORTS POSITIVE PHASE 2B RESULTS FOR FIRST- AND BEST-IN-CLASS ULTRA-LONG ACTING GLP-1 RA CANDIDATE MET-097I, ENABLING RAPID TRANSITION INTO PHASE 3 * METSERA INC – MET-097I SHOWS 14.1% WEIGHT LOSS AFTER 28 WEEKS * METSERA INC – MET-097I SHOWS CLASS-LEADING TOLERABILITY IN TRIALS * METSERA INC – DATA SUPPORTS PHASE 3 INITIATION IN LATE 2025 Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Berlin (dpa) - Having someone you share a special emotional bond with, walk hand in…
Donville-les-Bains (dpa) – Try this delicious recipe for scallops, created by a Normandy restaurant famous…
Berlin (dpa) - The great thing about pumpkin is that it's incredibly versatile in the…
उदय राज आनंद, सीईओ – डोमेस्टिक बिजनेस, पारिजात इंडस्ट्रीज नई दिल्ली, 21 अक्टूबर: खरीफ़ सीजन के बाद, भारत का…
Los Angeles (tca/dpa) - My boyfriend turned 50 this year. He didn't buy an expensive…
Los Angeles (PA Media/dpa) - People have long been warned that eating late at night leads…